Download PDF
Drug Res (Stuttg) 2017; 67(12): 719-723
DOI: 10.1055/s-0043-117611
Original Article
© Georg Thieme Verlag KG Stuttgart · New York

Anti-Hyperglycaemic Effect of Cleome Rutidosperma in Alloxan-Induced Diabetic Albino Rats

Olayinka A. Oridupa
1   Department of Veterinary Physiology, Biochemistry & Pharmacology, University of Ibadan, Ibadan, Nigeria
,
Naomi O. Ovwighose
1   Department of Veterinary Physiology, Biochemistry & Pharmacology, University of Ibadan, Ibadan, Nigeria
,
Adebowale B. Saba
1   Department of Veterinary Physiology, Biochemistry & Pharmacology, University of Ibadan, Ibadan, Nigeria
› Author Affiliations
Further Information

Publication History

received 10 February 2017

accepted 24 July 2017

Publication Date:
12 September 2017 (online)

Also available at
    Permissions and Reprints

Abstract

The hypoglycaemic and antihyperglycaemic effects of methanol extract of leaves of Cleome rutidosperma (Cr) DC (Family: Capparidaceae) was investigated in Wistar rats. Fifty normoglycaemic male rats (120 g–200 g) were divided into groups A (hypoglycaemic study; n=20) and B (antihyperglycaemic study; n=30). Each experiment had one control group and three groups administered with Cr (100, 200 or 400 mg/kg) respectively. Group B had two additional groups of diabetic-untreated rats and glibenclamide-treated diabetic rats. Diabetes was induced in Group B rats (except control) fasted overnight for 12 h by intraperitoneal injection of Alloxan (100 mg/kg). Fasting blood glucose levels (FBGL) were determined and alloxan-treated rats with BGL >200 mg/dl 48 h post-induction were considered diabetic. Data obtained were analyzed using One-way ANOVA and Duncan Multiple Range Test (p<0.05). Cr-treated rats showed significant decline in BGL with noteworthy decline by day 3 post-treatment at the dose of 200 mg/kg (236.40±14.72 mg/dl) from 336.40±21.06 mg/dl. Cr at the dose of 200 mg/kg (72.20±6.18 mg/dl, 69.20±7.81 mg/dl, 137.80±7.15 mg/dl and 70.60±10.66 mg/dl) showed better glycemic control compared to glibenclamide (194.50±7.75 mg/dl, 253.75±7.20 mg/dl, 284.25±10.56 mg/dl and 156.00±10.80 mg/dl). Cr-treated rats also showed progressive weight gain through the course of the study. This study demonstrated Cr has antihyperglycemic effect with more rapid onset of action and better glycemic control compared to glibenclamide.

Key words

Cleome rutidosperma - diabetes mellitus - antihyperglycaemic effect
 

  • References

  • 1 Sharma K, Pareek A, Chauhan EK. Evaluation of hyperglycemic and hyperlipidemic mitigating impact of hibiscus Rosa sinensis (gudhal) flower in Type II diabetes mellitus subjects. Int J Appl Biol Pharmaceut Technol 2016; 7: 223-228
    PubMedGoogle Scholar
  • 2 American Diabetes Association. Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2009; 32 (Suppl. 01) S62-S67 doi:10.2337/dc09-S062
    CrossrefPubMedGoogle Scholar
  • 3 Masharani U, German MS. Greenspan's basic & clinical endocrinology. 9th ed. Gardner DG, Shoback D. (eds) 2011. Chapter 17 New York: McGraw-Hill Medical; ISBN 0-07-162243-8
    Google Scholar
  • 4 Vambergue A, Fajardy I. Consequences of gestational and pregestational diabetes on placental function and birth weight. World J Diabetes 2011; 2: 196-203
    CrossrefPubMedGoogle Scholar
  • 5 Porte D, Baskin DG, Schwartz MW. A Critical Role in Metabolic Homeostasis and disease from C. elegans to humans. Diabetes 2005; 54: 1264-1276 10.2337/diabetes.54.5.1264
    CrossrefPubMedGoogle Scholar
  • 6 Tuomi T, Santoro N, Caprio S. et al. The many faces of diabetes: A disease with increasing heterogeneity. Lancet 2014; 383: 1084-1094
    CrossrefPubMedGoogle Scholar
  • 7 Zhu X, Wallman J. Opposite effects of glucagon and insulin on compensation for spectacle lenses in chicks. Invest Ophthalmol Vis Sci. 2008; 50: 24-36 doi:10.1167/iovs.08-1708
    PubMedGoogle Scholar
  • 8 Hahr AJ, Molitch ME. Management of diabetes mellitus in patients with chronic kidney disease. Clinical Diabetes and Endocrinology 2015; 1: 2 doi:10.1186/s40842-015-0001-9
    CrossrefPubMedGoogle Scholar
  • 9 Inzucchi SE, Bergenstal RM, Buse JB et al. Management of hyperglycemia in type 2 diabetes: A patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). 2012;
    PubMed
  • 10 Bose A, Mondal S, Gupta JK. et al. Analgesic, anti-inflammatory and antipyretic activities of the ethanolic extract and its fractions of Cleome rutidosperma. Fitoterapia 2007; 78: 515-520
    CrossrefPubMedGoogle Scholar
  • 11 Bose A, Mondal S, Gupta JK. et al. Antioxidant and free radical scavenging activities of Cleome rutidosperma. Oriental Pharmacy and Experimental Medicine 2008; 8: 135-145 doi:10.3742/OPEM.2008.8.2.135
    CrossrefPubMedGoogle Scholar
  • 12 Bidla G, Titanji VPK, Joko B. et al. Antiplasmodial activity of seven plants used in African folk medicine. Indian J. Pharmacol. 2004; 36: 245-246
    PubMedGoogle Scholar
  • 13 Mondal S, Dash GK, Acharyya S. et al. Hypoglycaemic activity from the roots of Cleome rutidosperma DC. Biomed 2009; 4: 64-69
    PubMedGoogle Scholar
  • 14 Mondal S, Dash GK, Bal SK. Anthelmintic activity of Cleome rutidosperma DC. roots. Indian Drugs 2009; 46: 47-49
    PubMedGoogle Scholar
  • 15 Bose A, Mondal S, Gupta JK. et al. Studies on diuretic and laxative activity of ethanolic extract and its fractions of Cleome rutidosperma aerial parts. Pharmacognosy Mag 2006; 2: 27-31
    PubMedGoogle Scholar
  • 16 Chakraborty AK, Charde MS, Roy H. et al. Comparative study of antioxidant activity between ethanolic and aqueous extract of Cleome rutidosperma. Int J Pharmaceut Sci Res 2010; 1: 112 10.13040/IJPSR.0975-8232.1(11).112-16
    PubMedGoogle Scholar
  • 17 Adeyi AO, Idowu BA, Mafiana CF. et al. Rat model of food-induced non-obese-type 2 diabetes mellitus: comparative pathophysiology and histopathology. Int J Physiol Pathophysiol Pharmacol. 2012; 4: 51-58
    PubMedGoogle Scholar
  • 18 Kikumoto Y, Sugiyama H, Inoue T. et al. Sensitization to alloxan-induced diabetes and pancreatic cell apoptosis in acatalasemic mice. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2010; 1802: 240-246
    PubMedGoogle Scholar
  • 19 Oyedemi SO, Adewusi EA, Aiyegoro OA. et al. Antidiabetic and haematological effect of aqueous extract of stem bark of Afzelia africana (Smith) on streptozotocin-induced diabetic Wistar rats. Asian Pac J Trop Biomed. 2011; 1: 353-358
    CrossrefPubMedGoogle Scholar
  • 20 Bloomgarden ZT. Type 2 Diabetes in the Young: The evolving epidemic. Diabetes Care 2004; 27: 998-1010
    CrossrefPubMedGoogle Scholar
  • 21 Cooke DW, Plotnick L. Type 1 diabetes mellitus in pediatrics. Pediatr Rev. 2008; 29: 374-384 quiz 385 doi:10.1542/pir.29-11-374 PMID 18977856
    CrossrefPubMedGoogle Scholar
  • 22 Shim U, Lee H, Oh JY. et al. Sleep Disorder and Cardiovascular Risk Factors among Patients with Type 2 Diabetes Mellitus. Korean J. Intern. Med. 2011; 26: 277-284
    CrossrefPubMedGoogle Scholar
  • 23 Hamdy SM. Effect of Morus alba Linn extract on enzymatic activities in diabetic rats. Journal of Applied Sciences Research 2012; 8: 10-16
    PubMedGoogle Scholar
  • 24 Palanduz S, Ademoglu E, Gokkusu C. Plasma antioxidants and type 2 diabetes mellitus. Pharmacology 2001; 109: 309-318
    PubMedGoogle Scholar
  • 25 Maritim AC, Sanders RA, Watkins 3rd JB. Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol. 2003; 17: 24-38
    CrossrefPubMedGoogle Scholar
  • 26 Lenzen S. The mechanisms of alloxan- and streptozotocin-induced diabetes. Diabetologia 2008; 51: 216-226
    CrossrefPubMedGoogle Scholar
  • 27 Lodovicia M, Giovannellia L, Pitozzia V. et al. Oxidative DNA damage and plasma antioxidant capacity in type 2 diabetic patients with good and poor glycaemic control. Mutation Research 2008; 638: 98-102
    CrossrefPubMedGoogle Scholar
  • 28 Krentz AJ, Bailey CJ. Oral antidiabetic agents: current role in type 2 diabetes mellitus. Drugs 2005; 65: 385-411 doi:10.2165/00003495-200565030-00005 PMID 15669880
    CrossrefPubMedGoogle Scholar
  • 29 Espeland M, Bahnson JL, Wagenknecht L. et al. Reduction in Weight and Cardiovascular Disease Risk Factors in Individuals With Type 2 Diabetes: One-Year Results of the Look AHEAD Trial. Diabetes Care 2007; 30: 1374-1383 10.2337/dc07-0048
    CrossrefPubMedGoogle Scholar
  • 30 Okoro IO, Umar IA, Atawodi SE. et al. Antidiabetic effect of Cleome rutidosperma Dc and Senecio biafrae (Oliv. & Hiern) extracts in streptozotocin-induced diabetic rats. Int J Pharm Sci Res 2014; 5: 2490-07 doi:10.13040/IJPSR.0975-8232.5(6).2480-2497
    PubMedGoogle Scholar
  • 31 Xu Z, Wang X, Zhou M. et al. The antidiabtic activity of total lignan from Fructusarctii against alloxan-induced diabetes in mice and rats. Phytother Res. 2008; 22: 97-101
    CrossrefPubMedGoogle Scholar
  • 32 Hu FB, Li TY, Colditz GA. et al. Television watching and other sedentary behaviors in relation to risk of obesity and type 2 diabetes mellitus in women. JAMA 2003; 289: 1785-1791
    CrossrefPubMedGoogle Scholar